NRAS and melanoma: In humans, NRAS and BRAF genes are mutated in 15% to 30% and in 50% to 70% of human melanomas, respectively, leading to their permanent activation [41] followed by promotion of proliferation, survival, invasion, and angiogenesis of melanoma [42, 43].